In data from 18 studies of people with chronic obstructive pulmonary disease (COPD), the prevalence of glucocorticoid-induced hyperglycaemia was 38.6%. Systemic glucocorticoid treatment for COPD was ...
Early results from the United Kingdom's RECOVERY trial this summer were a welcome piece of good news in the midst of the COVID-19 pandemic. Critically ill patients on ventilators who received ...
Please provide your email address to receive an email when new articles are posted on . Glucocorticoids are still one of the most commonly used treatments for rheumatoid arthritis, with an estimated ...
Chronic graft-versus-host disease (GVHD), a major complication of allogeneic stem-cell transplantation, becomes glucocorticoid-refractory or glucocorticoid-dependent in approximately 50% of patients.
The addition of low-dose glucocorticoids to standard care for community-acquired pneumonia was linked to a lower risk of death compared with standard care alone in a Kenyan trial. The absolute ...
A recent study from the Institute of Biomedicine at the University of Eastern Finland shows that the glucocorticoid receptor can both promote and inhibit prostate cancer progression, depending on the ...
Patients with inflammatory rheumatic musculoskeletal diseases (iRMDs) receiving low-dose glucocorticoids should also receive preventive anti-osteoporotic therapy, according to study results presented ...
BOSTON — Crinecerfont, an investigational oral selective corticotropin-releasing factor type 1 receptor antagonist, benefits both adults and children with congenital adrenal hyperplasia (CAH) due to ...
A recent study from the Institute of Biomedicine at the University of Eastern Finland shows that the glucocorticoid receptor can both promote and inhibit prostate cancer progression, depending on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback